What is the “Synapse Creative Space” service launched by Fujifilm in Japan?

Teiichi Goto, President and CEO, Representative Director of FUJIFILM Corporation, announced that they will launch the “SYNAPSE Creative Space,” a service to support the development of AI technologies for image diagnosis at medical institutions and research organizations in Japan. 

The “SYNAPSE Creative Space” will be available starting from April 12. It is a cloud service that enables doctors and researchers to develop their own AI technologies to support image diagnosis without requiring programming knowledge.

Fujifilm and the National Cancer Center Japan have jointly developed this service, which is based on an AI technology development research platform.

Also Read: 13 People Who Are Making the Difference in AI Healthcare

What are the hurdles in developing AI technology to support Image Diagnosis?

• it requires a high-performance server and development environment
• it requires advanced engineering skills, such as programming, to design the learning model and execute the development process
• it requires many hours and effort to annotate or generate data for the AI to learn

How does “Synapse Creative Space” stand out?

• The “SYNAPSE Creative Space” is a service that enables a series of development processes, such as project management, annotation, learning, and AI technology testing, in the development of AI technology to support image diagnosis to be performed all at once in the cloud
• The “SYNAPSE Creative Space” has evolved to be even easier to use, including enhanced annotation support features that reflect requests received during trials conducted at more than 40 medical and research institutions in Japan since April 2022
• It strongly supports the development of AI technology to support image diagnosis
• It can also be used not only as a support tool for research and development but also as a teaching tool for the hands-on education of medical professionals and medical students

Also Read: Saudi Arabia to Become Global AI Powerhouse with  $40 Billion Investment

The widespread use of the “SYNAPSE Creative Space” is expected to promote the development of AI technologies to support image diagnosis for various diseases, including rare diseases. Fujifilm has already conducted joint research with the National Cancer Center Japan and Nagoya City University to develop two AI technologies.

The service has also been piloted at six medical schools, graduate schools, and medical colleges to support AI training for more than 300 medical students. By providing this service, Fujifilm aims to support the development of AI technology while also focusing on social implementation and educational support.

Also Read: What is NVIDIA Healthcare Generative AI Microservices for Drug Discovery and MedTech